NCT03106051View on ClinicalTrials.gov

Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions

CompletedOBSERVATIONAL
Enrollment

526

Participants

Timeline

Start Date

February 18, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

August 12, 2020

Conditions
Arthritis, Psoriatic
Trial Locations (2)

20354

Klinikum Stephansplatz, Hamburg

22767

Rheumatology at Struenseehaus, Altona

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT03106051 - Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions | Biotech Hunter | Biotech Hunter